Month: October 2016
-
Therapeutic Food-Triggered Gut Microbes in Development
A biologist at Rice University in Houston is developing synthetic intestinal microbe circuits that respond to food to release therapeutic proteins.
-
Yom Kippur 5777
We’ll be observing Yom Kippur today, the day of atonement and holiest day in the Jewish calendar. Regular posting will resume tomorrow.
-
Worms-On-A-Chip Drug Screening System Designed
A system using live roundworms on a microfluidics chip and high-speed image analysis can quickly and simultaneously screen nearly 100 drug compounds.
-
Trial Shows Ovarian Cancer Drug Safety, Therapy Potential
A clinical trial shows an experimental therapy addressing a common cancer-causing mutation is safe, with early indications of its efficacy against ovarian cancer.
-
Breast Cancer Drug Costs Vary Among Insured Patients
Women receiving chemotherapy for breast cancer can face widely different costs for their treatments, regardless of effectiveness, even if they have health insurance.
-
Funds Provided for Developing RNA-Based Zika Vaccine
Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus.
-
Grant Funding Study of Gut Microbe Protection Drug
A biotechnology company developing drugs that protect the natural microbial balance in the gastrointestinal tract is receiving funds to learn how its drugs affect antibiotic resistance.
-
Adverse Effects Reports in Cancer Trials Seen Lacking
A review of clinical trials testing targeted treatments or immunotherapies for cancer show most of the studies got low scores on a standard scale for reporting adverse side effects.
-
Fuel Cell Vehicles Reach Market, Seek Critical Mass
As the first hydrogen fuel cell vehicles go on sale, a group of companies and government agencies are seeking ways to encourage sales to help meet national goals for reducing greenhouse gases.
-
Vaccine Stops Livestock Infections Without Antibiotics
A veterinary medical team at Kansas State University developed a vaccine that protects livestock against dangerous liver and skin infections without antibiotics.